Castleark Management’s Pacira BioSciences PCRX Stock Holding History

Castleark Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-49,580	Closed	-$2.89M	–	321
2022 Q2	$2.89M	Sell	49,580 -11,080	-18%	-$726K	0.15%	137
2022 Q1	$4.63M	Buy	+60,660	New	+$4.04M	0.2%	117
2019 Q1	–	Sell	-119,440	Closed	-$5.14M	–	394
2018 Q4	$5.14M	Sell	119,440 -106,105	-47%	-$4.95M	0.22%	143
2018 Q3	$11.1M	Buy	+225,545	New	+$9.75M	0.32%	107
2016 Q1	–	Sell	-144,060	Closed	-$11.1M	–	403
2015 Q4	$11.1M	Buy	+144,060	New	+$8.16M	0.33%	77
2015 Q1	–	Sell	-129,325	Closed	-$11.5M	–	373
2014 Q4	$11.5M	Buy	129,325 +41,986	+48%	+$3.97M	0.3%	96
2014 Q3	$6.11M	Sell	87,339 -4,000	-4%	-$389K	0.17%	137
2014 Q2	$8.39M	Buy	91,339 +4,000	+5%	+$305K	0.23%	98
2014 Q1	$6.11M	Sell	87,339 -39,399	-31%	-$2.68M	0.17%	137
2013 Q4	$7.29M	Buy	126,738 +45,902	+57%	+$2.41M	0.21%	88
2013 Q3	$7.83M	Sell	80,836 -47,999	-37%	-$1.75M	0.22%	117
2013 Q2	$3.74M	Buy	+128,835	New	+$3.73M	0.12%	131

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Loomis, Sayles & Company

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return